Ticker
STOKCompany Name
STOKE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 384.51M | $ 199.89M | 51.99% |
3/31/2025 | $ 406.89M | $ 190.91M | 46.92% |
12/31/2024 | $ 271.56M | $ 36.55M | 13.46% |
9/30/2024 | $ 293.32M | $ 16.74M | 5.71% |
6/30/2024 | $ 307.76M | $ 15.16M | 4.92% |
3/31/2024 | $ 205.18M | $ 7.84M | 3.82% |
12/31/2023 | $ 228.34M | $ 8.78M | 3.85% |
9/30/2023 | $ 239.89M | $ 9.25M | 3.85% |
6/30/2023 | $ 256.92M | $ 8.84M | 3.44% |
3/31/2023 | $ 281.8M | $ 14.56M | 5.17% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for STOKE THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Assets [ $ 199.94M ]
(=) GPA [ 0% ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 4.14K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.15% |
median | 15.34% |
std | 19.95% |